Fig. 7
From: Redox/NIR dual-responsive MoS2 for synergetic chemo-photothermal therapy of cancer
Biodistribution of MoS2–SS–HA–CPT in lung-cancer-cell-bearing mice. a Tissue biodistribution of Mo in major organs 6, 12, 24, and 48 h after intravenous administration of MoS2–SS–HA–CPT at a dose of 1.2 mg/kg. b Mo level in the tumors at 6, 12, 24, and 48 h after intravenous administration of MoS2–SS–HA–CPT with or without preinjection of free HA (50 mg/kg). The data are expressed as the mean ± SD (n = 3) and were analyzed by ANOVA. *p < 0.05, **p < 0.01